Alcon AG (ALCC)

Currency in CHF
52.86
-0.30(-0.56%)
Closed·
ALCC is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
52.7254.06
52 wk Range
47.8074.34
Key Statistics
Bid/Ask
52.84 / 52.88
Prev. Close
53.16
Open
53.74
Day's Range
52.72-54.06
52 wk Range
47.8-74.34
Volume
1.27M
Average Volume (3m)
1.39M
1-Year Change
-25.4443%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALCC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
76.03
Upside
+43.83%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 5 consecutive years

Alcon AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

22 Buy
3 Hold
1 Sell
Ratings:
26 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 76.03
(+43.83% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Citi
Buy82.00+55.13%90.00MaintainJun 11, 2026
Deutsche Bank
Buy70.00+32.43%77.00MaintainMay 12, 2026
Goldman Sachs
Buy71.00+34.32%82.00MaintainMay 11, 2026
BofA Securities
Sell55.00+4.05%-MaintainMay 06, 2026
UBS
Buy95.00+79.72%-MaintainMar 11, 2026

Earnings

Latest Release
May 06, 2026
EPS / Forecast
0.85 / 0.81
Revenue / Forecast
2.69B / 2.7B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.67%
Dividend Yield
0.53%
Industry Median 2.37%
Annualised payout
0.28
Paid annually
5-Years Growth
+25.59%
Growth Streak

ALCC Income Statement

Compare ALCC to Peers and Sector

Metrics to compare
ALCC
Peers
Sector
Relationship
P/E Ratio
40.4x24.3x−0.5x
PEG Ratio
−1.530.130.00
Price/Book
1.5x1.9x2.6x
Price / LTM Sales
3.1x2.1x3.0x
Upside (Analyst Target)
51.3%10.8%58.6%
Fair Value Upside
Unlock22.6%10.2%Unlock

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
193.91M39.76%10.31B
Other Institutional Investors
85.26M17.48%4.53B
Public Companies & Retail Investors
208.53M42.76%11.09B
Total
487.7M100.00%25.93B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Government Pension Fund Global2.41%11,762,399625,289
Vanguard STAR Funds - Vanguard Total International Stock ETF1.48%7,242,021384,986

People Also Watch

120.22
NOVN
-1.52%
39.51
UBSG
+1.57%
82.58
ABBN
+1.18%
121.40
SRENH
+0.54%
212.80
UHR
+1.67%

FAQ

What Is the Alcon (ALCC) Stock Price Today?

The Alcon stock price today is 52.86 CHF.

What Stock Exchange Does Alcon Trade On?

Alcon is listed and trades on the Switzerland Stock Exchange.

What Is the Stock Symbol for Alcon?

The stock symbol for Alcon is "ALCC."

What Is the Alcon Market Cap?

As of today, Alcon market cap is 25.78B CHF.

What Is Alcon's Earnings Per Share (TTM)?

The Alcon EPS (TTM) is 1.67.

When Is the Next Alcon Earnings Date?

Alcon will release its next earnings report on Aug 10, 2026.

From a Technical Analysis Perspective, Is ALCC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Alcon Stock Split?

Alcon has split 0 times.

How Many Employees Does Alcon Have?

Alcon has 25000 employees.

What is the current trading status of Alcon (ALCC)?

As of Jun 15, 2026, Alcon (ALCC) is trading at a price of 52.86 CHF, with a previous close of 53.16 CHF. The stock has fluctuated within a day range of 52.72 CHF to 54.06 CHF, while its 52-week range spans from 47.80 CHF to 74.34 CHF.

What Is Alcon (ALCC) Price Target According to Analysts?

The average 12-month price target for Alcon is 76.03 CHF, with a high estimate of 87.91077949 CHF and a low estimate of 50.93506906 CHF. 22 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +43.83% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.